InvestorsHub Logo
icon url

Kittykitty

01/27/23 5:06 PM

#400302 RE: Kentucky123 #400299

I have addressed the feasible reasons for delay enough times that I find it hard to restate, but I will summarize by saying that science is slow, there is considerable manipulation/corruption that requires strategy that may not be obvious and Missling does not have the psychology of an American. I really think you will be happy you did not sell in the long run. If you needed the money returned quickly, biotech was not a good choice. Otherwise, I believe it will pay off.
icon url

bb8675309

01/27/23 5:17 PM

#400303 RE: Kentucky123 #400299

Hard to say when to sell, Kentucky. This could have easily gone to $100.00 and you, me would have kicked ourselves for selling at $28.00. I sleep at night knowing it is the best company in the CNS space. I believe we should have a $5 to $10 billion MC with current drug trial results. GLTU